James Davison is the Director of Translational Genomics at GeneCentric Therapeutics, Inc., a position they began in 2023. Throughout their career, they have built and led cross-functional teams to develop biomarker-driven tests, integrating molecular data, clinical outcomes, and machine learning. With a PhD in Cell Biology and Physiology from the University of North Carolina at Chapel Hill, they have held various roles, including Senior Translational Genomics Scientist at GeneCentric and Research Analyst II at Duke University Health System. James has a strong foundation in oncology, collaborating with diverse professionals to drive innovation in clinical care.
This person is not in the org chart
This person is not in any teams
This person is not in any offices